Aetion Vice President of Growth and Strategic Partnerships Discusses RWE
Ian Rentsch recently became Vice President of Growth and Strategic Partnerships at Aetion. He previously held roles in clinical research [...]
[Webinar] RWE in Drug Development
Dr. Nicolle Gatto of Aetion, along with leaders from Sanofi and Janssen, will discuss the use of RWE (real world [...]
Panalgo Releases RWD Benchmarking Report
Healthcare analytics company Panalgo released its 2021 State of Healthcare Analytics Benchmarking Report, featuring insight into the use of RWD [...]
Using RWE to Make Cost Decisions: A New Report
A recent article, published in JMCP (the Journal of Managed Care and Specialty Pharmacy), considers how RWE (real world evidence) can be utilized when making economic decisions. ICER (the Institute for Clinical and Economic Review) has incorporated RWE in making its recommendations, but few other organizations have been as ready to make such a move.
Payer Engagement Summit Videos on RWD Now Available
ISPOR held its first Payer Engagement Summit in 2020 to discuss the issues facing payers worldwide. The Summit featured discussions [...]
Syapse Invests $68 Million in Expanding RWE to Improve Outcomes for Cancer Patients
Leading RWE (real world evidence) company Syapse has invested $68 million in a venture with Ally Bridge Group and Northpond [...]
Good News: RWE Shows Effectiveness of COVID-19 Vaccines
A recent study examines how the vaccines produced by Moderna and Pfizer might protect against COVID-19. RWE (real world evidence) [...]
Webinar on RWE and Progress During COVID-19 Pandemic
The COVID-19 Pandemic has driven many researchers to incorporate RWE (real world evidence) into clinical trials. However, it can often [...]
Case Study Shows Power of RWE
A new case study from Cardinal Health highlights the value of RWE (real world evidence) in clinical trials. This RWE [...]
Designing Clinical Trials During COVID-19 ERA
The ongoing pandemic has led to chaos in many industries, including in clinical trial design. The use of RWE (real [...]
Germany Announces RWE Data Collection for Novartis Zolgensma Gene Therapy
Germany’s Federal Joint Committee (GBA, Gemeinsamer Bundesausschuss) has announced a new registry study related to spinal muscular atrophy (SMA) drugs. [...]
RWE Provides Architecture for Healthcare Decisions
The many types of data resulting from RWE (real world evidence) provide substantial information for healthcare institutions, regulators, and pharmaceutical companies, [...]
Perspectives on Usable RWD in COVID-19 Era at Aetion Summit
The massive amount of RWD (real world data) has been a growing issue in the past several years. The COVID-19 [...]
RWD in a COVID-19 World
COVID-19 has been linked to the development of other, non-respiratory diseases including heart attacks. Understanding this correlation requires real world [...]
Good Data Holds Tremendous Value for Patients
Innovative use of good data can lead to better patient care pathways and models of care. Collecting, collating, and assessing [...]